521 related articles for article (PubMed ID: 17449065)
21. [DNA intercalators: their interaction with DNA and other cell components and their use in biological research].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1991; 33(10):3-31. PubMed ID: 1814033
[TBL] [Abstract][Full Text] [Related]
22. A molecular modeling study of B-DNA-intercalation complexes with amsacrine and related 9-anilino-acridines.
Fischer G; Pindur U
Pharmazie; 1999 Feb; 54(2):83-93. PubMed ID: 10084153
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanics and molecular dynamics studies of the intercalation of dynemicin-A with oligonucleotide models of DNA.
Cardozo MG; Hopfinger AJ
Mol Pharmacol; 1991 Dec; 40(6):1023-8. PubMed ID: 1758437
[TBL] [Abstract][Full Text] [Related]
24. Conformation and dynamics of drug-DNA intercalation.
Herzyk P; Neidle S; Goodfellow JM
J Biomol Struct Dyn; 1992 Aug; 10(1):97-139. PubMed ID: 1418749
[TBL] [Abstract][Full Text] [Related]
25. The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: molecular dynamics simulations.
Mazerski J; Martelli S; Borowski E
Acta Biochim Pol; 1998; 45(1):1-11. PubMed ID: 9701490
[TBL] [Abstract][Full Text] [Related]
26. DNA recognition by intercalators and hybrid molecules.
Waring MJ; Bailly C
J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671
[TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of tricyclic compounds with anilino substituents and their intercalation complexes with DNA sequences.
Loza-Mejía MA; Castillo R; Lira-Rocha A
J Mol Graph Model; 2009; 27(8):900-7. PubMed ID: 19269869
[TBL] [Abstract][Full Text] [Related]
28. DNA-binding drugs caught in action: the latest 3D pictures of drug-DNA complexes.
Boer DR; Canals A; Coll M
Dalton Trans; 2009 Jan; (3):399-414. PubMed ID: 19122895
[TBL] [Abstract][Full Text] [Related]
29. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes.
Pindur U; Marotto A; Schulze E; Fischer G
Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831
[TBL] [Abstract][Full Text] [Related]
30. Caffeine and other xanthines as cytochemical blockers and removers of heterocyclic DNA intercalators from chromatin.
Lyles MB; Cameron IL
Cell Biol Int; 2002; 26(2):145-54. PubMed ID: 11846444
[TBL] [Abstract][Full Text] [Related]
31. Binding of cationic dyes to DNA: distinguishing intercalation and groove binding mechanisms using simple experimental and numerical models.
Del Castillo P; Horobin RW; Blázquez-Castro A; Stockert JC
Biotech Histochem; 2010 Aug; 85(4):247-56. PubMed ID: 20560871
[TBL] [Abstract][Full Text] [Related]
32. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
33. The interaction between the novel intercalator diethidium cation and B-form DNA: a theoretical study.
Monaco RR; Polkosnik W
J Biomol Struct Dyn; 1996 Aug; 14(1):13-9. PubMed ID: 8877557
[TBL] [Abstract][Full Text] [Related]
34. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
35. Selective intercalation of six ligand molecules in a self-assembled triple helix.
Mateos-Timoneda MA; Kerckhoffs JM; Reinhoudt DN; Crego-Calama M
Org Biomol Chem; 2007 Feb; 5(3):447-9. PubMed ID: 17252126
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
37. Electrostatic factors in DNA intercalation.
Medhi C; Mitchell JB; Price SL; Tabor AB
Biopolymers; 1999; 52(2):84-93. PubMed ID: 10898854
[TBL] [Abstract][Full Text] [Related]
38. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells.
Schreck I; Chudziak D; Schneider S; Seidel A; Platt KL; Oesch F; Weiss C
Toxicology; 2009 May; 259(3):91-6. PubMed ID: 19428948
[TBL] [Abstract][Full Text] [Related]
39. Designing transcription factor architectures for drug discovery.
Blancafort P; Segal DJ; Barbas CF
Mol Pharmacol; 2004 Dec; 66(6):1361-71. PubMed ID: 15340042
[TBL] [Abstract][Full Text] [Related]
40. Drug discovery using receptors that modulate gene expression.
Lamb P; Rosen J
J Recept Signal Transduct Res; 1997; 17(1-3):531-43. PubMed ID: 9029513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
